Generation of multidrug resistant human tissues by overexpression of the ABCG2 multidrug transporter in embryonic stem cells

被引:10
|
作者
Erdei, Zsuzsa [1 ]
Schamberger, Anita [1 ]
Torok, Gyorgy [1 ]
Szebenyi, Kornelia [1 ]
Varady, Gyorgy [1 ]
Orban, Tamas I. [1 ]
Homolya, Laszlo [1 ]
Sarkadi, Balks [1 ,2 ]
Apati, Agota [1 ]
机构
[1] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary
[2] Semmelweis Univ, Inst Biophys & Radiat Biol, Budapest, Hungary
来源
PLOS ONE | 2018年 / 13卷 / 04期
关键词
SUBSTRATE-SPECIFICITY; PROTEIN TRANSPORTER; EXPRESSION PATTERN; DRUG TRANSPORTERS; NULL ALLELES; DIFFERENTIATION; SYSTEM; LOCALIZATION; BCRP/ABCG2; PHENOTYPE;
D O I
10.1371/journal.pone.0194925
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The ABCG2 multidrug transporter provides resistance against various endo- and xenobiotics, and protects the stem cells against toxins and stress conditions. We have shown earlier that a GFP-tagged version of ABCG2 is fully functional and may be used to follow the expression, localization and function of this transporter in living cells. In the present work we have overexpressed GFP-ABCG2, driven by a constitutive (CAG) promoter, in HUES9 human embryonic stem cells. Stem cell clones were generated to express the wild-type and a substrate-mutant (R482G) GFP-ABCG2 variant, by using the Sleeping Beauty transposon system. We found that the stable overexpression of these transgenes did not change the pluripotency and growth properties of the stem cells, nor their differentiation capacity to hepatocytes or cardiomyocytes. ABCG2 overexpression provided increased toxin resistance in the stem cells, and protected the derived cardiomyocytes against doxorubicin toxicity. These studies document the potential of a stable ABCG2 expression for engineering toxin-resistant human pluripotent stem cells and selected stem cell derived tissues.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Mitoxantrone is expelled by the ABCG2 multidrug transporter directly from the plasma membrane
    Homolya, Laszlo
    Orban, Tamas I.
    Csanady, Laszlo
    Sarkadi, Balazs
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2011, 1808 (01): : 154 - 163
  • [42] The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids
    Holland, M. L.
    Lau, D. T. T.
    Allen, J. D.
    Arnold, J. C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (05) : 815 - 824
  • [43] Is ATP binding responsible for initiating drug translocation by the multidrug transporter ABCG2?
    McDevitt, Christopher A.
    Crowley, Emily
    Hobbs, Gemma
    Starr, Kate J.
    Kerr, Ian D.
    Callaghan, Richard
    FEBS JOURNAL, 2008, 275 (17) : 4354 - 4362
  • [44] Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays
    Hegedus, Csilla
    Szakacs, Gergely
    Homolya, Laszlo
    Orban, Tamas I.
    Telbisz, Agnes
    Jani, Marton
    Sarkadi, Balazs
    ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (01) : 47 - 56
  • [45] The multidrug-resistance transporter ABCG2 (BCRP/MXR/ABCP) is highly expressed in human gallbladder epithelial cells
    Aust, S
    Jaeger, W
    Klimpfinger, M
    Tucek, G
    Wrba, F
    Obrist, P
    Ozvegy, C
    Penner, E
    Thalhammer, T
    GASTROENTEROLOGY, 2003, 124 (04) : A730 - A730
  • [46] Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter
    Telbisz, Agnes
    Hegedus, Csilla
    Ozvegy-Laczka, Csilla
    Goda, Katalin
    Varady, Gyorgy
    Takats, Zoltan
    Szabo, Eszter
    Sorrentino, Brian P.
    Varadi, Andras
    Sarkadi, Balazs
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 45 (1-2) : 101 - 109
  • [47] Expression Levels of the ABCG2 Multidrug Transporter in Human Erythrocytes Correspond to Pharmacologically Relevant Genetic Variations
    Kasza, Ildiko
    Varady, Gyoergy
    Andrikovics, Hajnalka
    Koszarska, Magdalena
    Tordai, Attila
    Scheffer, George L.
    Nemeth, Adrienn
    Szakacs, Gergely
    Sarkadi, Balazs
    PLOS ONE, 2012, 7 (11):
  • [48] Expression, Function and Trafficking of the Human ABCG2 Multidrug Transporter Containing Mutations in an Unstructured Cytoplasmic Loop
    Mozner, Orsolya
    Zambo, Boglarka
    Bartos, Zsuzsa
    Gergely, Anna
    Szabo, Kata Sara
    Jezso, Balint
    Telbisz, Agnes
    Varady, Gyoergy
    Homolya, Laszlo
    Hegedus, Tamas
    Sarkadi, Balazs
    MEMBRANES, 2023, 13 (10)
  • [49] Prospective Drug Candidates as Human Multidrug Transporter ABCG2 Inhibitors: an In Silico Drug Discovery Study
    Ibrahim, Mahmoud A. A.
    Badr, Esraa A. A.
    Abdelrahman, Alaa H. M.
    Almansour, Nahlah Makki
    Shawky, Ahmed M.
    Mekhemer, Gamal A. H.
    Alrumaihi, Faris
    Moustafa, Mahmoud F.
    Atia, Mohamed A. M.
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2021, 79 (02) : 189 - 200
  • [50] Prospective Drug Candidates as Human Multidrug Transporter ABCG2 Inhibitors: an In Silico Drug Discovery Study
    Mahmoud A. A. Ibrahim
    Esraa A. A. Badr
    Alaa H. M. Abdelrahman
    Nahlah Makki Almansour
    Ahmed M. Shawky
    Gamal A. H. Mekhemer
    Faris Alrumaihi
    Mahmoud F. Moustafa
    Mohamed A. M. Atia
    Cell Biochemistry and Biophysics, 2021, 79 : 189 - 200